Publications by Peter Szodoray

156 publications found

Publications 2024

  1. Podgorica M, Drivet E, Viken JK, Richman A, Vestbøstad J, Szodoray P, Kvam AK, Wik HS, Tjønnfjord GE, Munthe LA, Frietze S, Schjerven H (2024)
    Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
    Eur J Haematol (in press)
    DOI 10.1111/ejh.14164, PubMed 38192186

Publications 2022

  1. Balogh L, Szabó K, Pucsok JM, Jámbor I, Gyetvai Á, Mile M, Barna L, Szodoray P, Tarr T, Csiki Z, Papp G (2022)
    The Effect of Aerobic Exercise and Low-Impact Pilates Workout on the Adaptive Immune System
    J Clin Med, 11 (22)
    DOI 10.3390/jcm11226814, PubMed 36431291
  2. Dunlock VE, Arp AB, Singh SP, Charrin S, Nguyen V, Jansen E, Schaper F, Beest MT, Zuidscherwoude M, van Deventer SJ, Nakken B, Szodoray P, Demaria MC, Wright MD, Querol Cano L, Rubinstein E, van Spriel AB (2022)
    Tetraspanin CD53 controls T cell immunity through regulation of CD45RO stability, mobility, and function
    Cell Rep, 39 (13), 111006
    DOI 10.1016/j.celrep.2022.111006, PubMed 35767951
  3. Imbery JF, Heinzelbecker J, Jebsen JK, McGowan M, Myklebust C, Bottini N, Stanford SM, Skånland SS, Tveita A, Tjønnfjord GE, Munthe LA, Szodoray P, Nakken B (2022)
    T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation
    Br J Haematol, 198 (3), 556-573
    DOI 10.1111/bjh.18285, PubMed 35655388

Publications 2021

  1. Papp G, Szabó K, Jámbor I, Mile M, Berki AR, Arany AC, Makra G, Szodoray P, Csiki Z, Balogh L (2021)
    Regular Exercise May Restore Certain Age-Related Alterations of Adaptive Immunity and Rebalance Immune Regulation
    Front Immunol, 12, 639308
    DOI 10.3389/fimmu.2021.639308, PubMed 33936054
  2. Szabó K, Jámbor I, Szántó A, Horváth IF, Tarr T, Nakken B, Szodoray P, Papp G (2021)
    The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren's Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution
    Front Immunol, 12, 639975
    DOI 10.3389/fimmu.2021.639975, PubMed 33815392
  3. Szodoray P, Andersen TK, Heinzelbecker J, Imbery JF, Huszthy PC, Stanford SM, Bogen B, Landsverk OB, Bottini N, Tveita A, Munthe LA, Nakken B (2021)
    Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity
    Cell Rep, 36 (6), 109525
    DOI 10.1016/j.celrep.2021.109525, PubMed 34380042

Publications 2020

  1. Griger Z, Danko K, Nemeth G, Hassan Z, Aszalos Z, Szabo K, Bodoki L, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A (2020)
    Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis
    Int J Ophthalmol, 13 (9), 1443-1450
    DOI 10.18240/ijo.2020.09.17, PubMed 32953585
  2. Szekanecz Z, Gomez I, Soós B, Bodoki L, Szamosi S, András C, Juhász B, Váróczy L, Antal-Szalmás P, Szodoray P, Bittner N, Árkosy P, Illés Á, Szűcs G, Dankó K, Bender T, Tamási L, Szekanecz É (2020)
    [Oncorheumatology: relationship between malignancies and musculoskeletal diseases]
    Orv Hetil, 161 (28), 1151-1165
    DOI 10.1556/650.2020.31800, PubMed 32609623
  3. Szekanecz Z, Gomez I, Soós B, Bodoki L, Szamosi S, András C, Juhász B, Váróczy L, Antal-Szalmás P, Szodoray P, Bittner N, Árkosy P, Illés Á, Szűcs G, Dankó K, Bender T, Tamási L, Szekanecz É, Hungarian OncoRheumatology Network (HORN) initiative (2020)
    Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases
    Autoimmun Rev, 19 (11), 102658
    DOI 10.1016/j.autrev.2020.102658, PubMed 32942035

Publications 2019

  1. Barta Z, Czompa L, Rentka A, Zold E, Remenyik J, Biro A, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A (2019)
    Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease
    Biomed Res Int, 2019, 8310583
    DOI 10.1155/2019/8310583, PubMed 30729131
  2. Czompa L, Barta Z, Ziad H, Nemeth G, Rentka A, Aszalos Z, Zold E, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A (2019)
    Corneal Manifestations of Inflammatory Bowel Disease
    Semin Ophthalmol, 34 (7-8), 543-550
    DOI 10.1080/08820538.2019.1684525, PubMed 31657260
  3. Kemeny-Beke A, Szodoray P (2019)
    Ocular manifestations of rheumatic diseases
    Int Ophthalmol, 40 (2), 503-510
    DOI 10.1007/s10792-019-01183-9, PubMed 31583550
  4. Szucs G, Szekanecz Z, Aszalos Z, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A (2019)
    A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis
    Ocul Immunol Inflamm, 29 (1), 81-89
    DOI 10.1080/09273948.2019.1657467, PubMed 31577461

Publications 2018

  1. Diószegi Á, Tarr T, Nagy-Vincze M, Nánásy-Vass M, Veisz R, Bidiga L, Dezső B, Balla J, Szodoray P, Szekanecz Z, Soltész P (2018)
    Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment
    Lupus, 27 (9), 1552-1558
    DOI 10.1177/0961203318768890, PubMed 29635999
  2. Griger Z, Danko K, Bodoki L, Aszalos Z, Nemeth G, Ziad H, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A (2018)
    Corneal Involvement of Patients with Polymyositis and Dermatomyositis
    Ocul Immunol Inflamm, 28 (1), 58-66
    DOI 10.1080/09273948.2018.1547407, PubMed 30444429
  3. Nagy A, Rentka A, Nemeth G, Ziad H, Szücs G, Szekanecz Z, Gesztelyi R, Zsuga J, Aszalos Z, Szodoray P, Kemeny-Beke A (2018)
    Corneal Manifestations of Systemic Sclerosis
    Ocul Immunol Inflamm, 27 (6), 968-977
    DOI 10.1080/09273948.2018.1489556, PubMed 30015530
  4. Szabó K, Bodoki L, Nagy-Vincze M, Vincze A, Zilahi E, Szodoray P, Dankó K, Griger Z (2018)
    Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort
    Biomed Res Int, 2018, 6416378
    DOI 10.1155/2018/6416378, PubMed 30498759

Publications 2017

  1. Chen JQ, Papp G, Póliska S, Szabó K, Tarr T, Bálint BL, Szodoray P, Zeher M (2017)
    MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome
    PLoS One, 12 (3), e0174585
    DOI 10.1371/journal.pone.0174585, PubMed 28339495
  2. Nakken B, Papp G, Bosnes V, Zeher M, Nagy G, Szodoray P (2017)
    Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives
    Immunol Lett, 189, 13-18
    DOI 10.1016/j.imlet.2017.05.010, PubMed 28526580
  3. Papp G, Boros P, Nakken B, Szodoray P, Zeher M (2017)
    Regulatory immune cells and functions in autoimmunity and transplantation immunology
    Autoimmun Rev, 16 (5), 435-444
    DOI 10.1016/j.autrev.2017.03.011, PubMed 28286106
  4. Rentka A, Koroskenyi K, Harsfalvi J, Szekanecz Z, Szucs G, Szodoray P, Kemeny-Beke A (2017)
    Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis
    Ann Clin Biochem, 54 (5), 521-529
    DOI 10.1177/0004563217695843, PubMed 28193107
  5. Rentka A, Nagy A, Harsfalvi J, Szucs G, Szekanecz Z, Gesztelyi R, Szodoray P, Kemeny-Beke A (2017)
    Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis
    Rheumatol Int, 37 (11), 1835-1845
    DOI 10.1007/s00296-017-3794-2, PubMed 28884335
  6. Szabó MZ, Szodoray P, Kiss E (2017)
    Dyslipidemia in systemic lupus erythematosus
    Immunol Res, 65 (2), 543-550
    DOI 10.1007/s12026-016-8892-9, PubMed 28168401
  7. Zeher M, Papp G, Nakken B, Szodoray P (2017)
    Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications
    Autoimmun Rev, 16 (8), 817-825
    DOI 10.1016/j.autrev.2017.05.020, PubMed 28572052

Publications 2016

  1. Chen JQ, Papp G, Szodoray P, Zeher M (2016)
    The role of microRNAs in the pathogenesis of autoimmune diseases
    Autoimmun Rev, 15 (12), 1171-1180
    DOI 10.1016/j.autrev.2016.09.003, PubMed 27639156
  2. Chen JQ, Szodoray P, Zeher M (2016)
    Toll-Like Receptor Pathways in Autoimmune Diseases
    Clin Rev Allergy Immunol, 50 (1), 1-17
    DOI 10.1007/s12016-015-8473-z, PubMed 25687121
  3. Papp G, Horvath IF, Gyimesi E, Barath S, Vegh J, Szodoray P, Zeher M (2016)
    The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study
    Immunol Res, 64 (2), 404-11
    DOI 10.1007/s12026-015-8678-5, PubMed 26168768
  4. Rentka A, Harsfalvi J, Szucs G, Szekanecz Z, Szodoray P, Koroskenyi K, Kemeny-Beke A (2016)
    Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis
    Immunol Res, 64 (2), 619-26
    DOI 10.1007/s12026-015-8763-9, PubMed 26687127
  5. Szodoray P, Stanford SM, Molberg Ø, Munthe LA, Bottini N, Nakken B (2016)
    T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity
    J Allergy Clin Immunol, 138 (3), 839-851.e8
    DOI 10.1016/j.jaci.2016.01.035, PubMed 27056269

Publications 2015

  1. Bazsó A, Szodoray P, Sütő G, Shoenfeld Y, Poór G, Kiss E (2015)
    Importance of intestinal microenvironment in development of arthritis. A systematic review
    Immunol Res, 61 (1-2), 172-6
    DOI 10.1007/s12026-014-8593-1, PubMed 25407648
  2. Bazsó A, Szodoray P, Szappanos Á, Korda J, Pálfi P, Kiss E, Poór G (2015)
    Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature
    Mediators Inflamm, 2015, 657907
    DOI 10.1155/2015/657907, PubMed 26339139
  3. Gáspár K, Baráth S, Nagy G, Mócsai G, Gyimesi E, Szodoray P, Irinyi B, Zeher M, Remenyik É, Szegedi A (2015)
    Regulatory T-cell subsets with acquired functional impairment: important indicators of disease severity in atopic dermatitis
    Acta Derm Venereol, 95 (2), 151-5
    DOI 10.2340/00015555-1882, PubMed 24890798
  4. Nagy G, Huszthy PC, Fossum E, Konttinen Y, Nakken B, Szodoray P (2015)
    Selected Aspects in the Pathogenesis of Autoimmune Diseases
    Mediators Inflamm, 2015, 351732
    DOI 10.1155/2015/351732, PubMed 26300591
  5. Nakken B, Bodolay E, Szodoray P (2015)
    Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review
    Clin Rev Allergy Immunol, 49 (2), 152-62
    DOI 10.1007/s12016-014-8452-9, PubMed 25274451
  6. Nakken B, Nagy G, Huszthy PC, Fossum E, Konttinen Y, Szodoray P (2015)
    Inflammatory Mediators in Autoimmunity and Systemic Autoimmune Diseases
    Mediators Inflamm, 2015, 878712
    DOI 10.1155/2015/878712, PubMed 26346773
  7. Rentka A, Hársfalvi J, Berta A, Köröskényi K, Szekanecz Z, Szücs G, Szodoray P, Kemény-Beke Á (2015)
    Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis
    Mediators Inflamm, 2015, 573681
    DOI 10.1155/2015/573681, PubMed 26339137

Publications 2014

  1. Bodolay E, Prohászka Z, Paragh G, Csipő I, Nagy G, Laczik R, Demeter N, Zöld E, Nakken B, Szegedi G, Szodoray P (2014)
    Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease
    Immunol Res, 60 (1), 50-9
    DOI 10.1007/s12026-014-8552-x, PubMed 24838263
  2. Laczik R, Soltesz P, Szodoray P, Szekanecz Z, Kerekes G, Paragh G, Rajnavölgyi E, Abel G, Szegedi G, Bodolay E (2014)
    Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study
    Rheumatology (Oxford), 53 (11), 2035-43
    DOI 10.1093/rheumatology/keu236, PubMed 24917564
  3. Šenolt L, Grassi W, Szodoray P (2014)
    Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis?
    BMC Med, 12, 49
    DOI 10.1186/1741-7015-12-49, PubMed 24642071
  4. Szodoray P, Hajas A, Toth L, Szakall S, Nakken B, Soltesz P, Bodolay E (2014)
    The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome
    Lupus, 23 (10), 1079-84
    DOI 10.1177/0961203314533602, PubMed 24795068
  5. Vincze M, Dér H, Kerekes G, Szodoray P, Zeher M, Dankó K, Soltész P (2014)
    Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients
    Clin Rheumatol, 33 (11), 1635-41
    DOI 10.1007/s10067-014-2561-y, PubMed 24615538
  6. Zold E, Bodolay E, Dezső B, Soos G, Nakken B, Szodoray P (2014)
    Mixed connective tissue disease associated with autoimmune hepatitis and pulmonary fibrosis
    Isr Med Assoc J, 16 (11), 733-4
    PubMed 25558707

Publications 2013

  1. Bazso A, Bazso T, Szodoray P, Poor G, Kiss E (2013)
    Aseptic necrosis at multiple localisations in a lupus patient with lymphoma
    Osteoporos Int, 25 (4), 1415-7
    DOI 10.1007/s00198-013-2589-x, PubMed 24297095
  2. Hajas A, Barath S, Szodoray P, Nakken B, Gogolak P, Szekanecz Z, Zold E, Zeher M, Szegedi G, Bodolay E (2013)
    Derailed B cell homeostasis in patients with mixed connective tissue disease
    Hum Immunol, 74 (7), 833-41
    DOI 10.1016/j.humimm.2013.04.007, PubMed 23608739
  3. Hajas A, Szodoray P, Nakken B, Gaal J, Zöld E, Laczik R, Demeter N, Nagy G, Szekanecz Z, Zeher M, Szegedi G, Bodolay E (2013)
    Clinical course, prognosis, and causes of death in mixed connective tissue disease
    J Rheumatol, 40 (7), 1134-42
    DOI 10.3899/jrheum.121272, PubMed 23637328
  4. Jona A, Szodoray P, Illés A (2013)
    Immunologic pathomechanism of Hodgkin's lymphoma
    Exp Hematol, 41 (12), 995-1004
    DOI 10.1016/j.exphem.2013.09.014, PubMed 24099823
  5. Osnes LT, Nakken B, Bodolay E, Szodoray P (2013)
    Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies - novel tool for diagnostics and patient follow-up
    Autoimmun Rev, 12 (10), 967-71
    DOI 10.1016/j.autrev.2013.02.003, PubMed 23541481
  6. Szodoray P, Nakken B, Barath S, Csipo I, Nagy G, El-Hage F, Osnes LT, Szegedi G, Bodolay E (2013)
    Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders
    Hum Immunol, 74 (12), 1510-8
    DOI 10.1016/j.humimm.2013.08.003, PubMed 23974054

Publications 2012

  1. Kincse G, Varga J, Somogyi P, Szodoray P, Surányi P, Gaál J (2012)
    The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
    BMC Musculoskelet Disord, 13, 244
    DOI 10.1186/1471-2474-13-244, PubMed 23227959
  2. Konttinen YT, Fuellen G, Bing Y, Porola P, Stegaev V, Trokovic N, Falk SS, Liu Y, Szodoray P, Takakubo Y (2012)
    Sex steroids in Sjögren's syndrome
    J Autoimmun, 39 (1-2), 49-56
    DOI 10.1016/j.jaut.2012.01.004, PubMed 22300712
  3. Nakken B, Alex P, Munthe L, Szekanecz Z, Szodoray P (2012)
    Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases
    Clin Dev Immunol, 2012, 957151
    DOI 10.1155/2012/957151, PubMed 22474487
  4. Papp G, Barath S, Szegedi A, Szodoray P, Zeher M (2012)
    The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis
    Clin Rheumatol, 31 (9), 1293-9
    DOI 10.1007/s10067-012-2000-x, PubMed 22706443
  5. Szodoray P, Hajas A, Kardos L, Dezso B, Soos G, Zold E, Vegh J, Csipo I, Nakken B, Zeher M, Szegedi G, Bodolay E (2012)
    Distinct phenotypes in mixed connective tissue disease: subgroups and survival
    Lupus, 21 (13), 1412-22
    DOI 10.1177/0961203312456751, PubMed 22864236

Publications 2011

  1. Besenyei T, Gyetvai A, Szabó Z, Fekete A, Kapitány A, Szodoray P, Laki J, Soós L, Sipka S, Szegedi G, Lakos G, Szekanecz Z (2011)
    Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort
    Joint Bone Spine, 78 (6), 652-3
    DOI 10.1016/j.jbspin.2011.05.018, PubMed 21733730
  2. Kemény-Beke Á, Gesztelyi R, Bodnár N, Zsuga J, Kerekes G, Zsuga M, Biri B, Kéki S, Szodoray P, Berta A, Szekanecz Z, Szántó S (2011)
    Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters
    Joint Bone Spine, 78 (2), 184-7
    DOI 10.1016/j.jbspin.2010.05.009, PubMed 20620092
  3. Kerekes G, Soltész P, Szucs G, Szamosi S, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi G, Szekanecz Z (2011)
    Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis
    Isr Med Assoc J, 13 (3), 147-52
    PubMed 21608334
  4. Laczik R, Szodoray P, Veres K, Szomják E, Csípo I, Sipka S, Shoenfeld Y, Szekanecz Z, Soltész P (2011)
    Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome
    Lupus, 20 (7), 730-5
    DOI 10.1177/0961203311398884, PubMed 21505011
  5. Nagy G, Gáspár K, Irinyi B, Gál M, Tumpek J, Gyimesi E, Sipka S, Remenyik É, Szodoray P, Szegedi A (2011)
    Association between serum IL-16 levels and the degree of sensitization in patients with atopic dermatitis
    Int Arch Allergy Immunol, 156 (1), 69-74
    DOI 10.1159/000321959, PubMed 21447961
  6. Nakken B, Munthe LA, Konttinen YT, Sandberg AK, Szekanecz Z, Alex P, Szodoray P (2011)
    B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives
    Autoimmun Rev, 11 (1), 28-34
    DOI 10.1016/j.autrev.2011.06.010, PubMed 21777703
  7. Papp G, Horvath IF, Barath S, Gyimesi E, Sipka S, Szodoray P, Zeher M (2011)
    Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis
    Scand J Rheumatol, 40 (3), 205-10
    DOI 10.3109/03009742.2010.528021, PubMed 21366383
  8. Papp G, Horvath IF, Barath S, Gyimesi E, Vegh J, Szodoray P, Zeher M (2011)
    Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis
    Clin Immunol, 142 (2), 150-9
    DOI 10.1016/j.clim.2011.09.014, PubMed 22036269
  9. Soltész P, Kerekes G, Dér H, Szücs G, Szántó S, Kiss E, Bodolay E, Zeher M, Timár O, Szodoray P, Szegedi G, Szekanecz Z (2011)
    Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment
    Autoimmun Rev, 10 (7), 416-25
    DOI 10.1016/j.autrev.2011.01.004, PubMed 21281743
  10. Szodoray P, Alex P (2011)
    Protein array diagnostics for guiding therapy in rheumatoid arthritis
    Mol Diagn Ther, 15 (5), 247-54
    DOI 10.1007/BF03256416, PubMed 22047152
  11. Szodoray P, Varoczy L, Papp G, Barath S, Nakken B, Szegedi G, Zeher M (2011)
    Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases
    Scand J Rheumatol, 41 (2), 110-5
    DOI 10.3109/03009742.2011.606788, PubMed 21936606
  12. Váróczy L, Páyer E, Kádár Z, Gergely L, Miltényi Z, Magyari F, Szodoray P, Illés A (2011)
    Malignant lymphomas and autoimmunity-a single center experience from Hungary
    Clin Rheumatol, 31 (2), 219-24
    DOI 10.1007/s10067-011-1807-1, PubMed 21735057
  13. Zeher M, Papp G, Szodoray P (2011)
    Autologous haemopoietic stem cell transplantation for autoimmune diseases
    Expert Opin Biol Ther, 11 (9), 1193-201
    DOI 10.1517/14712598.2011.580272, PubMed 21609185

Publications 2010

  1. Grenczer M, Pinter A, Zsuga J, Kemeny-Beke A, Juhasz B, Szodoray P, Tosaki A, Gesztelyi R (2010)
    The influence of affinity, efficacy, and slope factor on the estimates obtained by the receptorial responsiveness method (RRM): a computer simulation study
    Can J Physiol Pharmacol, 88 (11), 1061-73
    DOI 10.1139/y10-078, PubMed 21076494
  2. Kemeny-Beke A, Barta Z, Toth L, Nemes Z, Gesztelyi R, Modis L, Facsko A, Berta A, Szodoray P (2010)
    Total nasolacrimal duct obstruction in 2 patients with inflammatory bowel disease
    Inflamm Bowel Dis, 16 (10), 1637-9
    DOI 10.1002/ibd.21207, PubMed 20049946
  3. Kemény-Beke A, Szekanecz Z, Szántó S, Bodnár N, Módis L, Gesztelyi R, Zsuga J, Szodoray P, Berta A (2010)
    Safety and efficacy of etanercept therapy in ankylosing spondylitis patients undergoing phacoemulsification surgery
    Rheumatology (Oxford), 49 (11), 2220-1
    DOI 10.1093/rheumatology/keq288, PubMed 20833644
  4. Kiss E, Szodoray P (2010)
    Novel therapeutic approaches in systemic lupus erythematosus
    Front Biosci (Schol Ed), 2 (1), 221-8
    DOI 10.2741/s59, PubMed 20036942
  5. Konttinen YT, Stegaev V, Mackiewicz Z, Porola P, Hänninen A, Szodoray P (2010)
    Salivary glands - "an unisex organ'?
    Oral Dis, 16 (7), 577-85
    DOI 10.1111/j.1601-0825.2010.01669.x, PubMed 20412448
  6. Laczik R, Szodoray P, Veres K, Lakos G, Sipka S, Szegedi G, Soltész P (2010)
    Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome
    Autoimmunity, 43 (4), 334-9
    DOI 10.3109/08916930903540440, PubMed 20187701
  7. Nakken B, Szodoray P (2010)
    Accelerated atherosclerosis in rheumatoid arthritis: rationale for mannose-binding lectins?
    J Rheumatol, 37 (3), 482-4
    DOI 10.3899/jrheum.091364, PubMed 20197564
  8. Soltesz P, Bereczki D, Szodoray P, Magyar MT, Der H, Csipo I, Hajas A, Paragh G, Szegedi G, Bodolay E (2010)
    Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease
    Arthritis Res Ther, 12 (3), R78
    DOI 10.1186/ar2999, PubMed 20459625
  9. Szodoray P, Alex P, Knowlton N, Centola M, Dozmorov I, Csipo I, Nagy AT, Constantin T, Ponyi A, Nakken B, Danko K (2010)
    Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand
    Rheumatology (Oxford), 49 (10), 1867-77
    DOI 10.1093/rheumatology/keq151, PubMed 20591831
  10. Szodoray P, Kiss E (2010)
    Progressive Systemic Sclerosis- from the molecular background to innovative therapies
    Front Biosci (Elite Ed), 2 (2), 521-5
    DOI 10.2741/e110, PubMed 20036898
  11. Szodoray P, Papp G, Nakken B, Harangi M, Zeher M (2010)
    The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation
    Autoimmun Rev, 9 (6), 459-64
    DOI 10.1016/j.autrev.2009.12.011, PubMed 20044039
  12. Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E (2010)
    The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary
    Scand J Rheumatol, 40 (2), 122-6
    DOI 10.3109/03009742.2010.507220, PubMed 20977384
  13. Szodoray P, Varoczy L, Szegedi G, Zeher M (2010)
    Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications
    Scand J Rheumatol, 39 (1), 1-11
    DOI 10.3109/03009740903030324, PubMed 20132064
  14. Szomjak E, Der H, Kerekes G, Veres K, Csiba L, Toth J, Peter M, Soltesz P, Szodoray P (2010)
    Immunological parameters, including CXCL8 (IL-8) characterize cerebro- and cardiovascular events in patients with peripheral artery diseases
    Scand J Immunol, 71 (4), 283-91
    DOI 10.1111/j.1365-3083.2010.02368.x, PubMed 20384872
  15. Váncsa A, Gergely L, Ponyi A, Lakos G, Németh J, Szodoray P, Dankó K (2010)
    Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients
    Joint Bone Spine, 77 (2), 125-30
    DOI 10.1016/j.jbspin.2009.08.008, PubMed 20188618
  16. Váncsa A, Szodoray P, Kovács I, Kapitány A, Gergely L, Dankó K (2010)
    The association of common variable immune deficiency with idiopathic inflammatory myopathies
    Joint Bone Spine, 77 (6), 620-2
    DOI 10.1016/j.jbspin.2010.07.004, PubMed 20851031
  17. Vereckei E, Kriván G, Réti M, Szodoray P, Poór G, Kiss E (2010)
    Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis
    Scand J Rheumatol, 39 (2), 175-7
    DOI 10.3109/03009740902832753, PubMed 20337548
  18. Vereckei E, Szodoray P, Poor G, Kiss E (2010)
    Genetic and immunological processes in the pathomechanism of gluten-sensitive enteropathy and associated metabolic bone disorders
    Autoimmun Rev, 10 (6), 336-40
    DOI 10.1016/j.autrev.2010.12.001, PubMed 21172460
  19. Veres K, Szodoray P, Szekanecz Z, Lakos G, Kiss E, Laczik R, Sipka S, Bodolay E, Zeher M, Muszbek L, Szegedi G, Soltész P (2010)
    Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome
    Lupus, 19 (13), 1520-6
    DOI 10.1177/0961203310374336, PubMed 20685773
  20. Zold E, Szodoray P, Kappelmayer J, Gaal J, Csathy L, Barath S, Gyimesi E, Hajas A, Zeher M, Szegedi G, Bodolay E (2010)
    Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease
    Scand J Rheumatol, 39 (6), 490-7
    DOI 10.3109/03009741003781951, PubMed 20615161
  21. Zold E, Szodoray P, Nakken B, Barath S, Kappelmayer J, Csathy L, Hajas A, Sipka S, Gyimesi E, Gaal J, Barta Z, Hallay J, Szegedi G, Bodolay E (2010)
    Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease
    Autoimmun Rev, 10 (3), 155-62
    DOI 10.1016/j.autrev.2010.09.018, PubMed 20868777

Publications 2009

  1. Gaál J, Lakos G, Szodoray P, Kiss J, Horváth I, Horkay E, Nagy G, Szegedi A (2009)
    Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study
    Acta Derm Venereol, 89 (2), 140-4
    DOI 10.2340/00015555-0555, PubMed 19325997
  2. Hajas A, Szodoray P, Barath S, Sipka S, Rezes S, Zeher M, Sziklai I, Szegedi G, Bodolay E (2009)
    Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels
    J Rheumatol, 36 (9), 1930-6
    DOI 10.3899/jrheum.081314, PubMed 19684145
  3. Illes A, Varoczy L, Papp G, Wilson PC, Alex P, Jonsson R, Kovacs T, Konttinen YT, Zeher M, Nakken B, Szodoray P (2009)
    Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy
    Scand J Immunol, 69 (5), 387-400
    DOI 10.1111/j.1365-3083.2009.02237.x, PubMed 19508370
  4. Kapitany A, Tarr T, Gyetvai A, Szodoray P, Tumpek J, Poor G, Szegedi G, Sipka S, Kiss E (2009)
    Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome
    Ann N Y Acad Sci, 1173, 545-51
    DOI 10.1111/j.1749-6632.2009.04642.x, PubMed 19758197
  5. Kiss E, Kovacs L, Szodoray P (2009)
    Malignancies in systemic lupus erythematosus
    Autoimmun Rev, 9 (4), 195-9
    DOI 10.1016/j.autrev.2009.07.004, PubMed 19643208
  6. Kiss E, Lakos G, Szegedi G, Poor G, Szodoray P (2009)
    Anti-nuscleosome antibody, a reliable indicator for lupus nephritis
    Autoimmunity, 42 (5), 393-8
    DOI 10.1080/08916930903002446, PubMed 19811255
  7. Kovács L, Szodoray P, Kiss E (2009)
    Secondary tumours in Sjögren's syndrome
    Autoimmun Rev, 9 (4), 203-6
    DOI 10.1016/j.autrev.2009.07.002, PubMed 19602455
  8. Soltész P, Dér H, Kerekes G, Szodoray P, Szücs G, Dankó K, Shoenfeld Y, Szegedi G, Szekanecz Z (2009)
    A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases
    Clin Rheumatol, 28 (6), 655-62
    DOI 10.1007/s10067-009-1118-y, PubMed 19224126
  9. Szegedi A, Baráth S, Nagy G, Szodoray P, Gál M, Sipka S, Bagdi E, Banham AH, Krenács L (2009)
    Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion
    Br J Dermatol, 160 (5), 984-93
    DOI 10.1111/j.1365-2133.2009.09035.x, PubMed 19222459
  10. Szodoray P, Horvath IF, Papp G, Barath S, Gyimesi E, Csathy L, Kappelmayer J, Sipka S, Duttaroy AK, Nakken B, Zeher M (2009)
    The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome
    Rheumatology (Oxford), 49 (2), 211-7
    DOI 10.1093/rheumatology/kep374, PubMed 19946023
  11. Szodoray P, Papp G, Horvath IF, Barath S, Sipka S, Nakken B, Zeher M (2009)
    Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome
    Clin Exp Immunol, 157 (3), 343-9
    DOI 10.1111/j.1365-2249.2009.03966.x, PubMed 19664141
  12. Szodoray P, Szabó Z, Kapitány A, Gyetvai A, Lakos G, Szántó S, Szücs G, Szekanecz Z (2009)
    Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis
    Autoimmun Rev, 9 (3), 140-3
    DOI 10.1016/j.autrev.2009.04.006, PubMed 19427413
  13. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E (2009)
    Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus
    Autoimmunity, 42 (6), 497-506
    DOI 10.1080/08916930902882731, PubMed 19626489
  14. Zeher M, Horvath IF, Szanto A, Szodoray P (2009)
    Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome
    Thyroid, 19 (1), 39-45
    DOI 10.1089/thy.2007.0398, PubMed 19119981

Publications 2008

  1. András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, Dankó K (2008)
    Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study
    J Rheumatol, 35 (3), 438-44
    PubMed 18203322
  2. Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC (2008)
    Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors
    J Exp Med, 206 (1), 139-51
    DOI 10.1084/jem.20080611, PubMed 19103878
  3. Horvath IF, Szanto A, Csiki Z, Szodoray P, Zeher M (2008)
    Intrapulmonary rheumatoid nodules in a patient with long-standing rheumatoid arthritis treated with leflunomide
    Pathol Oncol Res, 14 (1), 101-4
    DOI 10.1007/s12253-008-9003-6, PubMed 18392955
  4. Horvath IF, Szodoray P, Zeher M (2008)
    Primary Sjögren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients
    Clin Rheumatol, 27 (12), 1479-83
    DOI 10.1007/s10067-008-0944-7, PubMed 18553114
  5. Pazár B, Gergely P, Nagy ZB, Gombos T, Pozsonyi E, Rajczy K, Balogh Z, Sevcic K, Orbán I, Szodoray P, Poór G (2008)
    Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients
    Clin Exp Rheumatol, 26 (6), 1146-52
    PubMed 19210888
  6. Soltesz P, Der H, Veres K, Laczik R, Sipka S, Szegedi G, Szodoray P (2008)
    Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction
    Rheumatology (Oxford), 47 (11), 1628-34
    DOI 10.1093/rheumatology/ken349, PubMed 18782854
  7. Szabo N, Csiki Z, Szanto A, Danko K, Szodoray P, Zeher M (2008)
    Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjögren's syndrome and poly/dermatomyositis
    Scand J Rheumatol, 37 (1), 23-9
    DOI 10.1080/03009740701640209, PubMed 18189191
  8. Szanto A, Csipo I, Horvath I, Biro E, Szodoray P, Zeher M (2008)
    Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren's syndrome: possible markers for a common secretory disorder
    Rheumatol Int, 28 (11), 1169-72
    DOI 10.1007/s00296-008-0582-z, PubMed 18431573
  9. Szodoray P, Gal I, Barath S, Aleksza M, Horvath IF, Gergely P, Szegedi G, Nakken B, Zeher M (2008)
    Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines
    Scand J Rheumatol, 37 (3), 205-12
    DOI 10.1080/03009740801910361, PubMed 18465456
  10. Szodoray P, Nakken B, Barath S, Gaal J, Aleksza M, Zeher M, Sipka S, Szilagyi A, Zold E, Szegedi G, Bodolay E (2008)
    Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease
    Int Immunol, 20 (8), 971-9
    DOI 10.1093/intimm/dxn056, PubMed 18550583
  11. Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, Szegedi G, Brun JG, Gesztelyi R, Zeher M, Bodolay E (2008)
    The complex role of vitamin D in autoimmune diseases
    Scand J Immunol, 68 (3), 261-9
    DOI 10.1111/j.1365-3083.2008.02127.x, PubMed 18510590
  12. Szodoray P, Szollosi Z, Gyimesi E, Takacs I, Mekkel G, Vegh J, Szilagyi A, Zeher M, Szegedi G, Bodolay E (2008)
    Sarcoidosis in patients with mixed connective tissue disease: clinical, genetic, serological and histological observations
    Rheumatol Int, 28 (8), 743-7
    DOI 10.1007/s00296-008-0519-6, PubMed 18196245
  13. Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E (2008)
    Vitamin D deficiency in undifferentiated connective tissue disease
    Arthritis Res Ther, 10 (5), R123
    DOI 10.1186/ar2533, PubMed 18928561

Publications 2007

  1. Alex P, Szodoray P, Knowlton N, Dozmorov IM, Turner M, Frank MB, Arthur RE, Willis L, Flinn D, Hynd RF, Carson C, Kumar A, El-Gabalawy HS, Centola M (2007)
    Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritis
    Clin Exp Rheumatol, 25 (4), 584-92
    PubMed 17888215
  2. Bodolay E, Seres I, Szodoray P, Csípo I, Jakab Z, Vegh J, Szilagyi A, Szegedi G, Paragh G (2007)
    Evaluation of paraoxonase activity in patients with mixed connective tissue disease
    J Rheumatol, 35 (2), 237-43
    PubMed 18085736
  3. Centola M, Szekanecz Z, Kiss E, Zeher M, Szegedi G, Nakken B, Szodoray P (2007)
    Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis
    Expert Rev Clin Immunol, 3 (5), 797-806
    DOI 10.1586/1744666X.3.5.797, PubMed 20477029
  4. Der H, Kerekes G, Veres K, Szodoray P, Toth J, Lakos G, Szegedi G, Soltesz P (2007)
    Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome
    Lupus, 16 (7), 497-503
    DOI 10.1177/0961203307080224, PubMed 17670848
  5. Fekete A, Soos L, Szekanecz Z, Szabo Z, Szodoray P, Barath S, Lakos G (2007)
    Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses
    J Autoimmun, 29 (2-3), 154-63
    DOI 10.1016/j.jaut.2007.07.002, PubMed 17826949
  6. Juhasz B, Der P, Szodoray P, Gesztelyi R, Lekli I, Bak I, Antal M, Maulik N, Tosaki A, Vecsernyes M (2007)
    Adrenocorticotrope hormone fragment (4-10) attenuates the ischemia/reperfusion-induced cardiac injury in isolated rat hearts
    Antioxid Redox Signal, 9 (11), 1851-61
    DOI 10.1089/ars.2006.1535, PubMed 17715999
  7. Soltész P, Prohászka Z, Füst G, Dér H, Kerekes G, Szodoray P, Zeher M, Szekanecz Z (2007)
    [The autoimmune features of vasculopathies]
    Orv Hetil, 148 Suppl 1, 53-7
    DOI 10.1556/OH.2007.28036, PubMed 17430795
  8. Soltesz P, Veres K, Laczik R, Der H, Csipo I, Timar O, Szomjak E, Szegedi G, Szodoray P (2007)
    Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease
    Thromb Haemost, 98 (2), 413-9
    PubMed 17721625
  9. Szodoray P, Koczok K, Szanto A, Horvath IF, Nakken B, Molnar I, Zeher M (2007)
    Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren's syndrome
    Clin Rheumatol, 27 (2), 195-9
    DOI 10.1007/s10067-007-0678-y, PubMed 17713716
  10. Teague BN, Pan Y, Mudd PA, Nakken B, Zhang Q, Szodoray P, Kim-Howard X, Wilson PC, Farris AD (2007)
    Cutting edge: Transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus
    J Immunol, 178 (12), 7511-5
    DOI 10.4049/jimmunol.178.12.7511, PubMed 17548583

Publications 2006

  1. Alex P, Szodoray P, Arthur E, Willis L, Hynd R, Flinn D, Centola M (2006)
    Influence of intraarticular corticosteroid administration on serum cytokines in rheumatoid arthritis
    Clin Rheumatol, 26 (5), 845-8
    DOI 10.1007/s10067-006-0419-7, PubMed 17021669
  2. Baráth S, Sipka S, Aleksza M, Szegedi A, Szodoray P, Végh J, Szegedi G, Bodolay E (2006)
    Regulatory T cells in peripheral blood of patients with mixed connective tissue disease
    Scand J Rheumatol, 35 (4), 300-4
    DOI 10.1080/03009740600709790, PubMed 16882595
  3. Brugos B, Kiss E, Szodoray P, Szegedi G, Zeher M (2006)
    Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary
    Scand J Immunol, 64 (4), 433-7
    DOI 10.1111/j.1365-3083.2006.01833.x, PubMed 16970686
  4. Centola M, Frank MB, Bolstad AI, Alex P, Szanto A, Zeher M, Hjelmervik TO, Jonsson R, Nakken B, Szegedi G, Szodoray P (2006)
    Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool
    Scand J Immunol, 64 (3), 236-42
    DOI 10.1111/j.1365-3083.2006.01802.x, PubMed 16918692
  5. Jarvis JN, Petty HR, Tang Y, Frank MB, Tessier PA, Dozmorov I, Jiang K, Kindzelski A, Chen Y, Cadwell C, Turner M, Szodoray P, McGhee JL, Centola M (2006)
    Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis
    Arthritis Res Ther, 8 (5), R154
    DOI 10.1186/ar2048, PubMed 17002793
  6. Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M (2006)
    Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus
    Hum Immunol, 67 (11), 924-30
    DOI 10.1016/j.humimm.2006.06.006, PubMed 17145372
  7. Szodoray P, Alex P, Chappell-Woodward CM, Madland TM, Knowlton N, Dozmorov I, Zeher M, Jarvis JN, Nakken B, Brun JG, Centola M (2006)
    Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system
    Rheumatology (Oxford), 46 (3), 417-25
    DOI 10.1093/rheumatology/kel306, PubMed 16936328
  8. Szodoray P, Alex P, Frank MB, Turner M, Turner S, Knowlton N, Cadwell C, Dozmorov I, Tang Y, Wilson PC, Jonsson R, Centola M (2006)
    A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis
    Rheumatology (Oxford), 45 (12), 1466-76
    DOI 10.1093/rheumatology/kel095, PubMed 16638801
  9. Szodoray P, Timar O, Veres K, Der H, Szomjak E, Lakos G, Aleksza M, Nakken B, Szegedi G, Soltesz P (2006)
    TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease
    Scand J Immunol, 64 (3), 336-44
    DOI 10.1111/j.1365-3083.2006.01816.x, PubMed 16918703
  10. Vegh J, Szodoray P, Kappelmayer J, Csipo I, Udvardy M, Lakos G, Aleksza M, Soltesz P, Szilágyi A, Zeher M, Szegedi G, Bodolay E (2006)
    Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension
    Scand J Immunol, 64 (1), 69-76
    DOI 10.1111/j.1365-3083.2006.01770.x, PubMed 16784493

Publications 2005

  1. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K (2005)
    Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome
    J Clin Immunol, 25 (3), 189-201
    DOI 10.1007/s10875-005-4091-5, PubMed 15981083
  2. Szodoray P, Alex P, Jonsson MV, Knowlton N, Dozmorov I, Nakken B, Delaleu N, Jonsson R, Centola M (2005)
    Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF
    Clin Immunol, 117 (2), 168-76
    DOI 10.1016/j.clim.2005.06.016, PubMed 16126006
  3. Szodoray P, Jonsson R (2005)
    The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome
    Scand J Immunol, 62 (5), 421-8
    DOI 10.1111/j.1365-3083.2005.01688.x, PubMed 16305638
  4. Szodoray P, Jonsson R, Brun JG, Zeher M (2005)
    Polymyalgia rheumatica in primary Sjögren's syndrome
    Rheumatol Int, 26 (5), 401-3
    DOI 10.1007/s00296-005-0010-6, PubMed 15988601

Publications 2004

  1. Szodoray P, Alex P, Brun JG, Centola M, Jonsson R (2004)
    Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system
    Scand J Immunol, 59 (6), 592-9
    DOI 10.1111/j.0300-9475.2004.01432.x, PubMed 15182255
  2. Szodoray P, Alex P, Dandapani V, Nakken B, Pesina J, Kim X, Wallis GL, Wilson PC, Jonsson R, Centola M (2004)
    Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis
    Scand J Immunol, 60 (1-2), 209-18
    DOI 10.1111/j.0300-9475.2004.01441.x, PubMed 15238091
  3. Szodoray P, Jellestad S, Alex P, Zhou T, Wilson PC, Centola M, Brun JG, Jonsson R (2004)
    Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF
    J Clin Immunol, 24 (6), 600-11
    DOI 10.1007/s10875-004-6240-7, PubMed 15622444

Publications 2003

  1. Jarvis JN, Dozmorov I, Jiang K, Frank MB, Szodoray P, Alex P, Centola M (2003)
    Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis
    Arthritis Res Ther, 6 (1), R15-R32
    DOI 10.1186/ar1018, PubMed 14979934
  2. Szodoray P, Bacskó G, Lakos G, Zeher M (2003)
    [Combined therapy in pregnancy with primary antiphospholipid syndrome]
    Orv Hetil, 144 (49), 2411-3
    PubMed 14725207
  3. Szodoray P, Barta Z, Lakos G, Szakáll S, Zeher M (2003)
    Coeliac disease in Sjögren's syndrome--a study of 111 Hungarian patients
    Rheumatol Int, 24 (5), 278-82
    DOI 10.1007/s00296-003-0360-x, PubMed 13680146
  4. Szodoray P, Jellestad S, Nakken B, Brun JG, Jonsson R (2003)
    Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry
    Lab Invest, 83 (12), 1839-48
    DOI 10.1097/01.lab.0000101703.80133.99, PubMed 14691302
  5. Szodoray P, Jellestad S, Teague MO, Jonsson R (2003)
    Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome
    Lab Invest, 83 (3), 357-65
    DOI 10.1097/01.LAB.0000059930.92336.E2, PubMed 12649336

Publications 2002

  1. Bodolay E, Aleksza M, Antal-Szalmás P, Végh J, Szodoray P, Soltész P, Szegedi A, Szekanecz Z (2002)
    Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease
    J Rheumatol, 29 (10), 2136-42
    PubMed 12375323
  2. Bodolay E, Gaál J, Végh J, Soltész P, Szodoray P, Lakos G, Nemes Z, Dezsö B, Szegedi G (2002)
    [Evaluation of survival in mixed connective tissue disease (MCTD)]
    Orv Hetil, 143 (45), 2543-8
    PubMed 12501560
  3. Csepregi A, Szodoray P, Zeher M (2002)
    Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up
    Scand J Immunol, 56 (6), 623-9
    DOI 10.1046/j.1365-3083.2002.01165.x, PubMed 12472675
  4. Jonsson R, Moen K, Vestrheim D, Szodoray P (2002)
    Current issues in Sjögren's syndrome
    Oral Dis, 8 (3), 130-40
    DOI 10.1034/j.1601-0825.2002.02846.x, PubMed 12108757
  5. Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R (2002)
    CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases
    Scand J Immunol, 56 (6), 561-71
    DOI 10.1046/j.1365-3083.2002.01168.x, PubMed 12472667

Publications 2001

  1. Szodoray P, Csepregi A, Héjjas M, Horányi M, Zeher M (2001)
    Study of hepatitis C virus infection in 213 Hungarian patients with Sjögren's syndrome
    Rheumatol Int, 21 (1), 6-9
    DOI 10.1007/s002960100125, PubMed 11678303

Publications 1999

  1. Gál I, Kiss E, Zeher M, Szodoray P, Szegedi G (1999)
    [Adult onset Still disease: comment on two cases]
    Orv Hetil, 140 (49), 2763-5
    PubMed 10628194
  2. Zeher M, Szodoray P, Gyimesi E, Szondy Z (1999)
    Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome
    Arthritis Rheum, 42 (8), 1673-81
    DOI 10.1002/1529-0131(199908)42:8<1673::AID-ANR16>3.0.CO;2-1, PubMed 10446867

Publications 1997

  1. Zeher M, Gyimesi E, Szodoray P, Szondy Z (1997)
    Expression of apoptosis-related Fas antigen and in vitro apoptosis of lymphocyte subsets from patients with primary Sjögren's syndrome: comment on the article by Lorenz et al
    Arthritis Rheum, 40 (10), 1912
    DOI 10.1002/art.1780401036, PubMed 9336438

Page visits: 1143